BioScrip Inc. (BIOS)
-NasdaqGS | Prev Close: | 16.18 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | 16.48 x 100 |
|---|
| 1y Target Est: | 17.93 |
|---|
| Beta: | 0.55 |
|---|
| Next Earnings Date: | 9-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 6.14 - 16.48 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 643,366 |
|---|
| Market Cap: | 1.09B |
|---|
| P/E (ttm): | 15.47 |
|---|
| EPS (ttm): | 1.05 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BioScrip Grows with CarePoint BuyoutZacks(Tue, Jun 18)
- BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD DisclosureEDGAR Online(Tue, Jun 18)
- 4 Merger and Acquisitions Stock Stories Causing a Monday Buzzat Wall St. Cheat Sheet(Mon, Jun 17)
- BioScrip will buy drug infusion company for $223MAP(Mon, Jun 17)
- BIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 17)
- Tesla Rides a New Upgrade, BioScrip Buys CarePoint, and 3 More Hot Stocksat Wall St. Cheat Sheet(Mon, Jun 17)
- BioScrip Extends The Consent Payment Deadline And Expiration Date For Its Previously Announced Tender Offer And Consent SolicitationPR Newswire(Mon, Jun 17)
- BioScrip To Acquire CarePoint Partners Home Infusion BusinessPR Newswire(Mon, Jun 17)
- Has BioScrip Made You Any Fast Money?at Motley Fool(Thu, Jun 6)
- BioScrip Announces Tender Offer And Consent SolicitationPR Newswire(Mon, Jun 3)
- BIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, Jun 3)
- [video] Where to Find Tomorrow's Growth Stocksat MarketWatch(Tue, May 28)
- [$$] Where to Find Tomorrow's Growth Stocksat Barrons.com(Sat, May 25)
- BioScrip To Present At Jefferies 2013 Global Healthcare ConferencePR Newswire(Thu, May 23)
- Do These Tuesday Upgrades Present a Buying Opportunity?at Motley Fool(Thu, May 23)
Key Statistics
| Forward P/E (1 yr): | 33.02 |
|---|
| P/S (ttm): | 1.55 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.31 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.04 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | 3.26 |
|---|
Business Summary
BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services.
View More